Abstract
ACE inhibitors (ACEIs) have now been shown to improve symptoms and survival in patients with mild, moderate and severe chronic heart failure. Their mechanism of action is thought to be a combination of RAAS suppression and augmentation of bradykinin and prostaglandins. Although ACE inhibitors improve hemodynamics post myocardial infarction, we do not yet have consistent data on their effects on symptoms or survival in these particular patients. One other potential benefit is their effects on reperfusion injury and free radicals. As yet only minor differences have been found to exist between different ACEIs but increasing attention is now being focussed in this direction.
Original language | English |
---|---|
Pages (from-to) | 187-197 |
Number of pages | 11 |
Journal | Pharmacology & Therapeutics |
Volume | 53 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1992 |